Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BURNETT

Showing results (11-20 of 921) with videos related to

Pageof 93
Sort By:
Nephrology News & Issues|November 1, 1989
Hypertension and renal disease among minorities. Genetic defect may increase susceptibility in blacksJ C Burnett
Journal of Human Hypertension|January 1, 1997
Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failureJ C Burnett
The Homoeopathic Physician|May 3, 2023
On the Use of Chloral Hydrate in Lethargic SomnolencyJ C Burnett
The Dental Assistant|August 1, 1972
How to write the minutes of that meetingM C Burnett
Nature|September 11, 2024
Long-lasting heart-failure treatment could be a game-changerJohn C Burnett
Current Protocols in Microbiology|September 5, 2008
Biosafety practices associated with potential agents of biocrime and biowarfareLouAnn C Burnett
Journal of Human Hypertension|June 1, 1989
Atrial natriuretic factor: implications in congestive heart failure and hypertensionJ C Burnett
The New England Journal of Medicine|May 14, 2020
Vericiguat - Another Victory for Targeting Cyclic GMP in Heart FailureJohn C Burnett
JACC. Heart Failure|November 24, 2023
Innovative Dual Targeting of the Phosphodiesterase Family and Cyclic GMP Pathway in Heart FailureJohn C Burnett
Mayo Clinic Proceedings|April 13, 2000
Biomedical research at Mayo Clinic: a tradition of collaboration and a vision for year 2000 and beyondJ C Burnett
Pageof 93

Showing results (11-20 of 921) with videos related to

Sort By:
Pageof 93
Nephrology News & Issues|November 1, 1989
Hypertension and renal disease among minorities. Genetic defect may increase susceptibility in blacksJ C Burnett
Journal of Human Hypertension|January 1, 1997
Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failureJ C Burnett
The Homoeopathic Physician|May 3, 2023
On the Use of Chloral Hydrate in Lethargic SomnolencyJ C Burnett
The Dental Assistant|August 1, 1972
How to write the minutes of that meetingM C Burnett
Nature|September 11, 2024
Long-lasting heart-failure treatment could be a game-changerJohn C Burnett
Current Protocols in Microbiology|September 5, 2008
Biosafety practices associated with potential agents of biocrime and biowarfareLouAnn C Burnett
Journal of Human Hypertension|June 1, 1989
Atrial natriuretic factor: implications in congestive heart failure and hypertensionJ C Burnett
The New England Journal of Medicine|May 14, 2020
Vericiguat - Another Victory for Targeting Cyclic GMP in Heart FailureJohn C Burnett
JACC. Heart Failure|November 24, 2023
Innovative Dual Targeting of the Phosphodiesterase Family and Cyclic GMP Pathway in Heart FailureJohn C Burnett
Mayo Clinic Proceedings|April 13, 2000
Biomedical research at Mayo Clinic: a tradition of collaboration and a vision for year 2000 and beyondJ C Burnett
Pageof 93